Slobodan P. Rendić, Rachel D. Crouch & F. Peter Guengerich. (2022) Roles of selected non-P450 human oxidoreductase enzymes in protective and toxic effects of chemicals: review and compilation of reactions. Archives of Toxicology 96:8, pages 2145-2246.
Crossref
Xiaoyan Pang, Chongzhuang Tang, Runcong Guo & Xiaoyan Chen. (2022) Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity. Pharmacology & Therapeutics 233, pages 108020.
Crossref
S. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. HopS. Cyrus Khojasteh, Harvey Wong, Donglu Zhang & Cornelis E.C.A. Hop. 2022. Discovery DMPK Quick Guide. Discovery DMPK Quick Guide
11
61
.
Kirk D. Kozminski, Jangir Selimkhanov, Scott Heyward & Michael A. Zientek. (2021) Contribution of Extrahepatic Aldehyde Oxidase Activity to Human Clearance. Drug Metabolism and Disposition 49:9, pages 743-749.
Crossref
David C. Pryde, Dharmendra B. Yadav & Rajib Ghosh. 2021. The Medicinal Chemist's Guide to Solving ADMET Challenges. The Medicinal Chemist's Guide to Solving ADMET Challenges
248
277
.
Pranav Shah, Vishal B. Siramshetty, Alexey V. Zakharov, Noel T. Southall, Xin Xu & Dac-Trung Nguyen. (2020) Predicting liver cytosol stability of small molecules. Journal of Cheminformatics 12:1.
Crossref
Suguru Kato, Abhi Shah, Mihaela Plesescu, Yoshinari Miyata, Jayaprakasam Bolleddula, Swapan Chowdhury & Xiaochun Zhu. (2020) Prediction of Human Disproportionate and Biliary Excreted Metabolites Using Chimeric Mice with Humanized Liver. Drug Metabolism and Disposition 48:10, pages 934-943.
Crossref
Shotaro Uehara, Nao Yoneda, Yuichiro Higuchi, Hiroshi Yamazaki & Hiroshi Suemizu. (2020) Human Aldehyde Oxidase 1–Mediated Carbazeran Oxidation in Chimeric TK-NOG Mice Transplanted with Human Hepatocytes. Drug Metabolism and Disposition 48:7, pages 580-586.
Crossref
Matthew A. Cerny, Amit S. Kalgutkar, R. Scott Obach, Raman Sharma, Douglas K. Spracklin & Gregory S. Walker. (2020) Effective Application of Metabolite Profiling in Drug Design and Discovery. Journal of Medicinal Chemistry 63:12, pages 6387-6406.
Crossref
Jiang Wei Zhang, Hai Bing Deng, Chun Ye Zhang, Jing Quan Dai, Qian Li, Qian Gang Zheng, Hui Xin Wan, Hong Ping Yu, Feng He, Yao Chang Xu, Sylvia Zhao & Ji Yue Jeff Zhang. (2019) In Vitro Metabolism by Aldehyde Oxidase Leads to Poor Pharmacokinetic Profile in Rats for c-Met Inhibitor MET401. European Journal of Drug Metabolism and Pharmacokinetics 44:5, pages 669-680.
Crossref
Deepak Dalvie & Li Di. (2019) Aldehyde oxidase and its role as a drug metabolizing enzyme. Pharmacology & Therapeutics 201, pages 137-180.
Crossref
Yildiz Yilmaz, Gareth Williams, Markus Walles, Nenad Manevski, Stephan Krähenbühl & Gian Camenisch. (2019) Comparison of Rat and Human Pulmonary Metabolism Using Precision-cut Lung Slices (PCLS). Drug Metabolism Letters 13:1, pages 53-63.
Crossref
Markus Brinkmann, Bogdan Barz, Danielle Carrière, Mirna Velki, Kilian Smith, Henriette Meyer-Alert, Yvonne Müller, Beat Thalmann, Kerstin Bluhm, Sabrina Schiwy, Simone Hotz, Helena Salowsky, Andreas Tiehm, Markus Hecker & Henner Hollert. (2019)
Bioactivation of Quinolines in a Recombinant Estrogen Receptor Transactivation Assay Is Catalyzed by
N
-Methyltransferases
. Chemical Research in Toxicology 32:4, pages 698-707.
Crossref
Jiarong Xie, Nur Fazilah Saburulla, Shiyan Chen, Siew Ying Wong, Ze Ping Yap, Linghua Harris Zhang & Aik Jiang Lau. (2019)
Evaluation of Carbazeran 4-Oxidation and
O
6
-Benzylguanine 8-Oxidation as Catalytic Markers of Human Aldehyde Oxidase: Impact of Cytosolic Contamination of Liver Microsomes
. Drug Metabolism and Disposition 47:1, pages 26-37.
Crossref
Cristiano Mota, Catarina Coelho, Silke Leimkühler, Enrico Garattini, Mineko Terao, Teresa Santos-Silva & Maria João Romão. (2018) Critical overview on the structure and metabolism of human aldehyde oxidase and its role in pharmacokinetics. Coordination Chemistry Reviews 368, pages 35-59.
Crossref
Shotaro Uehara, Yasuhiro Uno, Eriko Okamoto, Takashi Inoue, Erika Sasaki & Hiroshi Yamazaki. (2017) Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase. Drug Metabolism and Disposition 45:8, pages 883-886.
Crossref
David J. Wilkinson, Rosalind L. Southall, Mingguang Li, Lisa M. Wright, Lindsay J. Corfield, Thomas A. Heeley, Benjamin Bratby, Ranbir Mannu, Sarah L. Johnson, Victoria Shaw, Holly L. Friett, Louise A. Blakeburn, John S. Kendrick & Michael B. Otteneder. (2017) Minipig and Human Metabolism of Aldehyde Oxidase Substrates: In Vitro–In Vivo Comparisons. The AAPS Journal 19:4, pages 1163-1174.
Crossref
C. M. Fulkerson, D. Dhawan, D. R. Jones, V. E. Marquez, P. A. Jones, Z. Wang, Q. Wu, J. E. Klaunig, L. M. Fourez, P. L. Bonney & D. W. Knapp. (2017) Pharmacokinetics and toxicity of the novel oral demethylating agent zebularine in laboratory and tumor bearing dogs. Veterinary and Comparative Oncology 15:1, pages 226-236.
Crossref
R. S. Foti & D. K. Dalvie. (2016) Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics. Drug Metabolism and Disposition 44:8, pages 1229-1245.
Crossref
Dennis A. Smith & Thomas A. Baillie. 2015. Attrition in the Pharmaceutical Industry. Attrition in the Pharmaceutical Industry
83
105
.
Dennis A Smith. (2015) A new phase of drug discovery? The rise of PK/PD means extremely challenging work at the coalface. Bioanalysis 7:12, pages 1415-1417.
Crossref
Nenad Manevski, Kamal Kumar Balavenkatraman, Barbara Bertschi, Piet Swart, Markus Walles, Gian Camenisch, Hilmar Schiller, Olivier Kretz, Barbara Ling, Reto Wettstein, Dirk J. Schaefer, Francois Pognan, Armin Wolf & Karine Litherland. (2014) Aldehyde Oxidase Activity in Fresh Human Skin. Drug Metabolism and Disposition 42:12, pages 2049-2057.
Crossref
Fionn O’Hara, Aaron C. Burns, Michael R. Collins, Deepak Dalvie, Martha A. Ornelas, Alfin D. N. Vaz, Yuta Fujiwara & Phil S. Baran. (2014) A Simple Litmus Test for Aldehyde Oxidase Metabolism of Heteroarenes. Journal of Medicinal Chemistry 57:4, pages 1616-1620.
Crossref
R. Scott Obach. 2014. Handbook of Metabolic Pathways of Xenobiotics. Handbook of Metabolic Pathways of Xenobiotics
1
41
.
John T. Barr, Kanika Choughule & Jeffrey P. Jones. 2014. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism
167
186
.
Timothy J. Strelevitz, Christine C. Orozco & R. Scott Obach. (2012) Hydralazine As a Selective Probe Inactivator of Aldehyde Oxidase in Human Hepatocytes: Estimation of the Contribution of Aldehyde Oxidase to Metabolic Clearance. Drug Metabolism and Disposition 40:7, pages 1441-1448.
Crossref
Alexander V. LyubimovMichael Zientek, Ping Kang, Matthew J. Hutzler & Scott R. Obach. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
59
.
. 2012. Pharmacokinetics and Metabolism in Drug Design. Pharmacokinetics and Metabolism in Drug Design
111
158
.
David C. Pryde, Thien-Duc Tran, Peter Jones, Jonathan Duckworth, Martin Howard, Iain Gardner, Ruth Hyland, Rob Webster, Tracey Wenham, Sharan Bagal, Kiyoyuki Omoto, Richard P. Schneider & Jian Lin. (2012) Medicinal chemistry approaches to avoid aldehyde oxidase metabolism. Bioorganic & Medicinal Chemistry Letters 22:8, pages 2856-2860.
Crossref
J. Matthew Hutzler, Young-Sun Yang, Daniel Albaugh, Cody L. Fullenwider, Jennifer Schmenk & Michael B. Fisher. (2012) Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes. Drug Metabolism and Disposition 40:2, pages 267-275.
Crossref
Raman Sharma, Heather Eng, Gregory S. Walker, Gabriela Barreiro, Antonia F. Stepan, Kim F. McClure, Angela Wolford, Paul D. Bonin, Peter Cornelius & Amit S. Kalgutkar. (2011) Oxidative Metabolism of a Quinoxaline Derivative by Xanthine Oxidase in Rodent Plasma. Chemical Research in Toxicology 24:12, pages 2207-2216.
Crossref
Gregory S. Walker, Tim F. Ryder, Raman Sharma, Evan B. Smith & Amy Freund. (2011) Validation of Isolated Metabolites from Drug Metabolism Studies as Analytical Standards by Quantitative NMR. Drug Metabolism and Disposition 39:3, pages 433-440.
Crossref
David C. Pryde, Deepak Dalvie, Qiyue Hu, Peter Jones, R. Scott Obach & Thien-Duc Tran. (2010) Aldehyde Oxidase: An Enzyme of Emerging Importance in Drug Discovery. Journal of Medicinal Chemistry 53:24, pages 8441-8460.
Crossref
Angus NR Nedderman & Pat Wright. (2010) Looking back through the MIST: a perspective of evolving strategies and key focus areas for metabolite safety analysis. Bioanalysis 2:7, pages 1235-1248.
Crossref
Deepak Dalvie, Chenghong Zhang, Weichao Chen, Teresa Smolarek, R. Scott Obach & Cho-Ming Loi. (2010) Cross-Species Comparison of the Metabolism and Excretion of Zoniporide: Contribution of Aldehyde Oxidase to Interspecies Differences. Drug Metabolism and Disposition 38:4, pages 641-654.
Crossref
Dennis A. Smith & R. Scott Obach. (2009) Metabolites in Safety Testing (MIST): Considerations of Mechanisms of Toxicity with Dose, Abundance, and Duration of Treatment. Chemical Research in Toxicology 22:2, pages 267-279.
Crossref
Dieter Lang & Amit Kalgutkar. 2003. Drug Metabolizing Enzymes. Drug Metabolizing Enzymes
483
539
.
Gonzalo J. Diaz & E. James Squires. (2000) Role of Aldehyde Oxidase in the Hepatic in Vitro Metabolism of 3-Methylindole in Pigs. Journal of Agricultural and Food Chemistry 48:3, pages 833-837.
Crossref
A.David Rodrigues. (1994) Comparison of levels of aldehyde oxidase with cytochrome P450 activities in human liver in vitro. Biochemical Pharmacology 48:1, pages 199-200.
Crossref
Christine Beedham, Sally E. Bruce, David J. Critchley & David J. Rance. (1990) 1-Substituted phthalazines as probes of the substrate-binding site of mammalian molybdenum hydroxylases. Biochemical Pharmacology 39:7, pages 1213-1221.
Crossref
E.P. Fridman & V.N. Popova. (1988)
Species of the Genus
Papio
(
Cercopithecidae
) as Subjects of Biomedical Research: I. Biological Basis of Experiments on Baboons
. Journal of Medical Primatology 17:6, pages 291-307.
Crossref
C. Beedham, S. E. Bruce, D. J. Critchley, Y. Al-Tayib & D. J. Rance. (1987) Species variation in hepatic aldehyde oxidase activity. European Journal of Drug Metabolism and Pharmacokinetics 12:4, pages 307-310.
Crossref
Christine Beedham. 1987.
85
127
.
Christine Johnson, Christine Stubley-Beedham, J. Godfrey & P. Stell. (1985) Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochemical Pharmacology 34:24, pages 4251-4256.
Crossref